News in Brief

MilliporeSigma opens $115m life science centre in Massachusetts

By Staff Reporter

- Last updated on GMT

GettyImages/Feverpitched
GettyImages/Feverpitched

Related tags Life

MilliporeSigma has cut the ribbon on a life science site in Burlington that incorporates a biomanufacturing equipment education centre.

Ground was broken on the 280,000 sq ft facility in Burlington, Massachusetts in July 2016​, and 15 months later MilliporeSigma – the life science division of Germany’s Merck – has opened the doors on its $115m (€97m) investment.

The site will serve as a hub for drugmakers looking to find solutions for their bioprocessing needs, MilliporeSigma said, and includes an “M Lab Collaboration Center” ​offering a full-scale non-GMP pilot lab and process development lab expected to serve more than 500 customers per year.

CEO Udit Batra said the campus “is specifically designed to foster a hands-on, collaborative environment where customers and our scientists and engineers come together to solve the toughest problems in life science.”

Burlington replaces the company’s nearby Billerica lab, with 850 full-time employees currently at the relocating to the new campus.

The M Lab concept is being launched globally with MilliporeSigma offering the same services across eight sites from France to South Korea.

Related news

Show more

Related products

show more

Trends in Biopharmaceutical Raw Material Selection

Trends in Biopharmaceutical Raw Material Selection

Actylis – The Partner of Choice | 31-Jan-2023 | Business Advice

Join us as our in-house experts, along with Cecile Bellamy from Pfizer, discuss current and future trends in biopharmaceutical raw material selection.

eBook: mRNA prospects and scale-up solutions

eBook: mRNA prospects and scale-up solutions

Thermo Fisher Scientific - Biosciences | 01-Jan-2023 | Insight Guide

This mRNA eBook was created by Thermo Fisher Scientific, in collaboration with Genetic Engineering & Biotechnology News (GEN), to provide you with...

Create Better Biologic Treatments with Catalent

Create Better Biologic Treatments with Catalent

Catalent | 06-Dec-2022 | Product Brochure

Your biologics possess a high level of complexities and technical challenges. That’s why development is key to ensuring the successful delivery of your...

Related suppliers

Follow us

Products

View more

Webinars